Valuation: Mega Lifesciences

Market Cap 33.13B 1B 864M 812M 738M 1.39B 95.64B 1.41B 9.51B 3.72B 47.89B 3.76B 3.67B 159B P/E 2026 *
14.1x
P/E 2027 * 13.3x
Enterprise Value 28.74B 868M 749M 704M 640M 1.2B 82.96B 1.22B 8.25B 3.23B 41.54B 3.26B 3.19B 138B EV / Sales 2026 *
1.92x
EV / Sales 2027 * 1.8x
Free-Float
38.61%
Yield 2026 *
4.72%
Yield 2027 * 5.02%
1 day-2.56%
1 week-3.18%
3 months+8.57%
6 months-0.65%
Current year+13.43%
1 week 37.25
Extreme 37.25
39
1 month 36.5
Extreme 36.5
39.75
Current year 31.5
Extreme 31.5
40
1 year 27.75
Extreme 27.75
40
3 years 24.3
Extreme 24.3
46.75
5 years 24.3
Extreme 24.3
56.5
10 years 17.6
Extreme 17.6
56.5
Manager TitleAgeSince
Chief Executive Officer 64 31/12/1987
Director of Finance/CFO 62 31/12/1996
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 62 31/12/1997
Director/Board Member 64 31/12/2012
Director/Board Member 73 31/01/2013
Change 5-day change 1-year change 3-year change Capi.($)
-2.56%-3.18% - - 1B
Average -2.56%
Weighted average by Cap. -2.56%

Financials

2026 *2027 *
Net sales 14.98B 452M 391M 367M 334M 627M 43.23B 638M 4.3B 1.68B 21.65B 1.7B 1.66B 71.95B 15.75B 476M 411M 386M 351M 660M 45.47B 671M 4.52B 1.77B 22.77B 1.79B 1.75B 75.67B
Net income 2.35B 70.9M 61.23M 57.54M 52.33M 98.39M 6.78B 100M 674M 264M 3.39B 266M 260M 11.28B 2.5B 75.41M 65.13M 61.2M 55.66M 105M 7.21B 106M 717M 280M 3.61B 283M 277M 12B
Net Debt -4.39B -133M -114M -108M -97.85M -184M -12.68B -187M -1.26B -493M -6.35B -498M -487M -21.09B -4.73B -143M -123M -116M -105M -198M -13.65B -201M -1.36B -531M -6.83B -536M -524M -22.71B
Logo Mega Lifesciences
Mega Lifesciences Public Company Limited is a Thailand-based company, which is engaged in health and wellness industry. Its segments include Brands, Distribution and OEM. MEGA We Care is its branded products business, through which it develops, manufactures, markets and sells its own range of nutraceuticals, complementary medicines, prescription pharmaceuticals and over the counter (OTC) health products. Maxxcare serves as its prominent distribution arm, specializing in the marketing, sales, and distribution of a range of branded prescription pharmaceuticals, OTC medications and fast-moving consumer goods (FMCG) across key markets such as Myanmar, Vietnam and Cambodia. Its suite of services encompasses warehouse management, collections and value-added initiatives, including tailored marketing services for principals in the pharmaceutical and FMCG sectors. Its manufacturing facilities in Thailand, Australia and Indonesia also accept production orders from various third-party customers.
Employees
-
Date Price Change Volume
14/08/26 THB 38.00 -2.56% 2,863,700
13/08/26 THB 39.00 +1.30% 652,400
11/08/26 THB 38.50 -0.65% 466,500
10/08/26 THB 38.75 -1.27% 485,600
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
38.00THB
Average target price
42.71THB
Spread / Average Target
+12.41%

Quarterly revenue - Rate of surprise